CTM Castellum, Inc. Insider Trading

CTM COO Merriman buys 2,000 shares at $0.64 amid 58.4% decline from 52-week high; stock down 34.3% in 30 days.

Andrew Merriman, Chief Operating Officer of Castellum, purchased 2,000 shares at $0.64 on 2026-03-27, bringing his holdings to 536,000 shares. This modest acquisition follows significant recent price weakness: the stock trades at $0.62, a 58.4% decline from its 52-week high of $1.49, and has fallen 34.3% over the past 30 days. Merriman has a sparse transaction history (only 1 prior buy on record across all tickers), and the company itself reported negative full-year net income despite strong 18.1% annual revenue growth. The acquisition is small relative to his existing holdings (536,000 shares) and occurs during a steep drawdown, but without a consistent pattern of well-timed purchases or public statements, the significance of the insider activity remains limited.

CTM President Ives buys 2,000 shares at $0.62; stock down 58.4% from 52-week high amid fundamentals decline.

Glen R. Ives, President of Castellum Inc., purchased 2,000 shares at $0.62 on 2026-03-27, bringing his holdings to 199,616 shares (a 1.0% increase from 197,616 shares). This transaction occurs as the stock trades significantly below its 52-week high ($1.49), down 58.4% from that peak and down 34.3% over the past 30 days. The company's most recent quarter reported revenue of $14,619,687.00 and net income of $415,401.00, with annual revenue growth of 18.1%, but the company remains unprofitable on a full-year basis, which creates a mixed fundamental backdrop. Ives's cross-ticker trade history shows only 1 prior buy and his CTM-specific trade on 2026-03-26 occurred just one day prior to this purchase, but given the stock's severe valuation decline and ongoing unprofitability at the full-year level, the modest position increase warrants monitoring for potential deeper analysis.

President Ives Glen R purchases 10,000 CTM shares at $0.66; stock down 56.4% from 52-week high.

Glen R Ives, President of Castellum Inc., purchased 10,000 shares at $0.66 on 2026-03-26, increasing his holdings by 10,000 shares (+5.3% vs pre-transaction holdings of 187.6K shares). The purchase occurred as CTM trades at $0.65, down 56.4% from its 52-week high of $1.49 and down 28.8% over the past 30 days. While the company shows positive fundamentals including +18.1% annual revenue growth and quarterly revenue of $14.6M, it was unprofitable over its most recent full fiscal year, creating a disconnect between operational growth and bottom-line performance. The timing and magnitude of this insider purchase warrant monitoring given the steep recent price decline and the company's inability to convert its revenue growth into sustained profitability.

COO Andrew Merriman purchased 3,000 shares of CTM at $0.80, raising stake to 534,000 shares amid -47.0% decline from 52-week high

Andrew Merriman, Chief Operating Officer, purchased 3,000 shares at $0.80 on 2026-03-18, modestly increasing his holdings from 531,000 to 534,000 shares. The transaction occurs as CTM trades 47.0% below its 52-week high of $1.49, and the stock has declined 21.8% over the past 90 days. Fundamentally, the company generated $14.6M in quarterly revenue with annual growth of 18.1%, yet posted negative full-year net income despite recent quarterly profitability of $415.4K. The insider's small incremental purchase—representing just 0.6% growth in his holdings—coincides with depressed price action but offers limited evidence of material conviction given the modest share increase and the company's mixed financial profile (profitable quarter offset by full-year losses).

General Counsel Wright sells 500,000 CTM shares for $717,450 after 90-day rally of +306.7%

Jay O. Wright, General Counsel and Secretary of Castellum, Inc., executed 2 separate sales totaling 500,000 shares for $717,450.00 on 2025-03-05 and 2025-03-06 at a blended average price of $1.43. The sale reduces his holdings from 10,023,673 shares to 9,523,673 shares, a -5.0% reduction. This comes on the heels of a sharp 90-day rally of +306.7% and a 30-day surge of +59.8%, following a 52-week trough of $0.14. Notably, Wright's prior 5 open-market purchases at CTM (all in August–September 2024) were uniformly well-timed at the 90-day horizon, with returns ranging from +3.1% to +54.6%, establishing a pattern of favorable market entry timing at this ticker. The company remains unprofitable (full-year net income was negative) with trailing-quarter net income of $-1,280,092.00 despite recent quarterly revenue of $11,608,691.00 and +7.2% annual revenue growth, creating a backdrop where a significant sale after sustained price appreciation warrants investor attention to potential insider perspective on near-term momentum.

CTM General Counsel Wright buys 272,300 shares at $0.16; stock -69.2% from 52-week high, company unprofitable.

Jay O. Wright, General Counsel and Secretary of Castellum, Inc., purchased 272,300 shares at $0.16 on 2024-09-04, increasing his holdings by 2.8% to 10,126,372 shares. This buy follows a pattern of five prior purchases at CTM in late August and early September 2024. The stock is trading at $0.16, down -69.2% from its 52-week high of $0.52, though it has gained +15.4% over the prior 30 days. However, the company fundamentals remain concerning: it reported net income of $-1.8M on quarterly revenue of $11.5M and was unprofitable over its most recent full fiscal year. Across his broader cross-ticker trading history, Wright's seven prior open-market buys averaged a 90-day return of -54.6% with a 0.00% win rate, indicating a weak pattern of timing execution, though outcomes at CTM remain unmeasurable at the 90-day horizon.

Wright (General Counsel) bought 44,400 CTM shares at $0.16 on 2024-09-03; 5 prior CTM buys in 2-month span; company unprofitable.

Jay O. Wright, General Counsel and Secretary of Castellum, Inc., purchased 44,400 shares at $0.16, bringing his holdings to 9,854,072 shares—a 0.5% increase. This transaction is the sixth open-market buy at CTM in less than two months, following purchases on 2024-09-04, 2024-08-29, 2024-08-28, 2024-08-14, and 2024-06-21. Wright's cross-ticker track record shows a 0.00% 90-day win rate across 7 prior buys with an average 90-day return of -54.6%, indicating a pattern of purchasing before declines. The underlying company reported quarterly revenue of $11,522,388.00 but posted a net loss of $1,846,735.00, with full-year profitability negative; the stock trades at $0.16, down 69.2% from its 52-week high of $0.52. The sustained buy-every-few-days pattern combined with poor cross-ticker timing history and persistent unprofitability creates a picture that warrants careful review of whether these purchases reflect opportunistic conviction or reflect other dynamics.

General Counsel buys 61,597 shares of CTM at $0.16 on 2024-08-29; stock -67.3% from 52-week high.

Jay O. Wright, General Counsel and Secretary of Castellum, Inc., purchased 61,597 shares at $0.16 on 2024-08-29, adding to his existing stake of 9,748,075 shares. This buy comes as the stock trades at $0.17, down -67.3% from its 52-week high of $0.52, and follows similar acquisitions the prior day (2024-08-28) and two weeks earlier (2024-08-14). The company generated $11,522,388.00 in revenue over its latest quarter but reported a net loss of $1,846,735.00; full-year net income was negative. Across Wright's cross-ticker open-market trading history, 5 prior buys averaged a -54.6% return over 90 days with a 0% win rate, and at CTM specifically, his only measurable 90-day outcome (a 2023-03-31 buy) declined -54.6%; neither pattern supports a read of prescient accumulation at a depressed level.

General Counsel Wright buys 97,903 shares of CTM at $0.16 on 2024-08-28; stock now $0.17, down -67.3% from 52-week high.

General Counsel Jay O. Wright purchased 97,903 shares at $0.16, increasing holdings to 9,748,075 shares in a micro-cap company trading at $0.17, well below its 52-week high of $0.52. The company reported negative net income of $-1,846,735.00 for its most recent full fiscal year, though revenue growth was positive at 7.2% year-over-year. Wright's same-ticker purchase history shows recent acquisitions on 2024-08-29 and 2024-08-14 with outcomes not yet measurable, while an earlier 2023-03-31 buy at CTM produced a -54.6% 90-day return. His cross-ticker track record of 5 prior buys delivered an average 90-day return of -54.6% with a 0.00% win rate over the 90-day measurement period, suggesting a pattern of poorly-timed open-market purchases. The repetitive buying at these depressed levels against a backdrop of operational losses and poor historical timing provides minimal conviction signal for equity investors.

CTM General Counsel Wright buys 115,240 shares at $0.14; stock down 69.2% YTD, company unprofitable with -$1.8M net income.

General Counsel Jay O Wright purchased 115,240 shares at $0.14 on 2024-08-14, expanding his holdings to 9.65M shares. The transaction occurs within a context of significant price deterioration: the stock trades at $0.16 currently, down 69.2% from its 52-week high of $0.52 and down 27.3% over the past 30 days. Castellum reported a net loss of $1.8M in its most recent quarter and was unprofitable on a full-year basis, despite posting 7.2% annual revenue growth. Wright's cross-ticker track record shows a 0.00% win rate at the 90-day mark across 3 prior open-market buys, and his prior CTM trades have produced mixed results: two June 2024 purchases showed short-term gains but the March 2023 buy showed a -54.6% 90-day outcome. The timing of this buy (after a steep 34.4% decline over 90 days) and its modest size relative to existing holdings (+1.2%) do not clearly signal conviction during a period of operational losses and sustained stock weakness.